steatotic liver disease | Department of Medicine Blog

Risk of Hepatocellular Carcinoma or Hepatic Decompensation Associated With Steatotic Liver Disease in People With and Without HIV

Torgersen J, Newcomb CW, Skanderson M, Kidwai-Khan F, Carbonari DM, Tate JP, Mezzacappa C, Cartwright EJ, Bhattacharya D, Lim JK, Price JC, Taddei TH, Justice[...]

By afschroeder • October 21, 2026

Design of Screening Cardiometabolic Opportunities Using Transformative Echocardiography Artificial Intelligence (SCOUT-Echo-AI)

Eusuff S, Kim J, Fatima Z, Yalcinkaya D, Sahashi Y, Sandhu A, Nguyen LH, Ambrosy AP, Cheng PP, Chang ST, Go AS, Ahmad FS, Cheung[...]

By afschroeder • October 20, 2026

Selecting Pharmacologic Interventions for MASH

Pan JJ, Horwich BH, Chahine M, Gutierrez JA, Saab S. Selecting Pharmacologic Interventions for MASH. Dig Dis Sci. 2026 Jun 17. doi: 10.1007/s10620-026-10003-x. Epub ahead[...]

By afschroeder • June 18, 2026

Sex Disparities in Alcohol-Associated Liver Disease and Subtype Differences in Alcohol-attributable Cancers in the United States

Danpanichkul P, Pang Y, Mahendru T, Tothanarungroj P, Díaz LA, Arab JP, Jatupornpakdee P, Muthiah MD, Duangsonk K, Choi WM, Huang DQ, Kim D, Noureddin[...]

By sjmartinez • April 11, 2025

Increased mortality from alcohol use disorder, alcohol-associated liver disease, and liver cancer from alcohol among older adults in the United States: 2000 to 2021

Danpanichkul P, Duangsonk K, Tham EKJ, Tothanarungroj P, Auttapracha T, Prasitsumrit V, Sim B, Tung D, Barba R, Wong RJ, Leggio L, Yang JD, Chen[...]

By sjmartinez • December 20, 2024